Novo Nordisk · 10 hours ago
Internship - Dashboard Development
Novo Nordisk is a global pharmaceutical company dedicated to improving health and defeating chronic diseases. The internship position offers hands-on experience in designing and implementing dashboards for data integration processes, along with responsibilities in data analysis, visualization, and collaboration with system analysts and data engineers.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Dashboard Design & Development: Create interactive dashboards to monitor daily job runs in the Informatica environment, ensuring visibility into job status, performance, and error handling
Data Analysis & Visualization: Collect and analyze job execution data, identify trends, and present insights through clear visualizations
Automation & Reporting: Develop automated reporting mechanisms for stakeholders to track job health and performance metrics
Collaboration: Work closely with system analysts and data engineers to understand requirements and optimize dashboard functionality
Qualification
Required
Must be a current student enrolled or recently graduated (graduation date no earlier than May 2026) at/from an accredited college or university pursuing at least a bachelor's degree
Conscientious self-starter with good organizational skills, project management skills and attention to detail
Ability to balance multiple projects and priorities, must be able to multi-task
Strong interpersonal communication and ability to collaborate with teams; must effectively operate independently, across functional lines, and with internal customers
Demonstrated personal initiative, self-motivation, flexibility, adaptability and willingness to learn
Proficient in Microsoft Office Tools including Word, Excel, PowerPoint, etc
Preferred
A completed or in progress undergraduate degree in Computer Science, Data Science, AI or a related discipline preferred
Strong academic record with a preferred cumulative GPA of 3.0 or higher
Company
Novo Nordisk
Novo Nordisk is a healthcare company that produces and distributes insulin and other diabetes drugs to treat chronic diseases.
Funding
Current Stage
Public CompanyTotal Funding
$22M2018-12-05Post Ipo Equity· $22M
1981-07-09IPO
Recent News
Labiotech UG
2026-01-24
bloomberglaw.com
2026-01-24
Company data provided by crunchbase